Marshall Wace North America’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$84.5M	Buy	204,845 +24,726	+14%	+$10.3M	0.36%	55
2021 Q2	$66.6M	Sell	180,119 -13,470	-7%	-$4.5M	0.28%	74
2021 Q1	$56.1M	Buy	+193,589	New	+$53.8M	0.23%	98
2020 Q3	–	Sell	-14,903	Closed	-$2.6M	–	1252
2020 Q2	$2.6M	Buy	+14,903	New	+$2.38M	0.02%	513
2019 Q4	–	Sell	-27,777	Closed	-$3.68M	–	1331
2019 Q3	$3.68M	Buy	+27,777	New	+$3.72M	0.02%	423
2019 Q2	–	Sell	-508	Closed	-$74K	–	1233
2019 Q1	$74K	Sell	508 -1,022	-67%	-$134K	﹤0.01%	1175
2018 Q4	$173K	Buy	+1,530	New	+$192K	﹤0.01%	981
2018 Q3	–	Sell	-57,307	Closed	-$6.43M	–	992
2018 Q2	$6.43M	Buy	+57,307	New	+$6.2M	0.04%	454
2017 Q4	–	Sell	-58,103	Closed	-$6.28M	–	1403
2017 Q3	$6.28M	Sell	58,103 -50,672	-47%	-$5.21M	0.04%	483
2017 Q2	$11M	Sell	108,775 -328,504	-75%	-$30.2M	0.08%	298
2017 Q1	$39.4M	Buy	+437,279	New	+$37.1M	0.31%	90